AU2020904152A0 - Use of Cannabidiol for the Treatment of Psychological Distress - Google Patents

Use of Cannabidiol for the Treatment of Psychological Distress

Info

Publication number
AU2020904152A0
AU2020904152A0 AU2020904152A AU2020904152A AU2020904152A0 AU 2020904152 A0 AU2020904152 A0 AU 2020904152A0 AU 2020904152 A AU2020904152 A AU 2020904152A AU 2020904152 A AU2020904152 A AU 2020904152A AU 2020904152 A0 AU2020904152 A0 AU 2020904152A0
Authority
AU
Australia
Prior art keywords
cannabidiol
treatment
psychological distress
psychological
distress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020904152A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emyria
Original Assignee
Emyria
Filing date
Publication date
Application filed by Emyria filed Critical Emyria
Publication of AU2020904152A0 publication Critical patent/AU2020904152A0/en
Priority to US18/035,396 priority Critical patent/US20240058363A1/en
Priority to CA3197966A priority patent/CA3197966A1/en
Priority to JP2023527979A priority patent/JP2023549173A/en
Priority to PCT/AU2021/051235 priority patent/WO2022099347A1/en
Priority to EP21890379.7A priority patent/EP4243795A1/en
Priority to AU2021378820A priority patent/AU2021378820A1/en
Priority to KR1020237017129A priority patent/KR20230107257A/en
Pending legal-status Critical Current

Links

AU2020904152A 2020-11-12 2020-11-12 Use of Cannabidiol for the Treatment of Psychological Distress Pending AU2020904152A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US18/035,396 US20240058363A1 (en) 2020-11-12 2021-10-22 Use of cannabidiol for the treatment of psychological distress
CA3197966A CA3197966A1 (en) 2020-11-12 2021-10-22 Use of cannabidiol for the treatment of psychological distress
JP2023527979A JP2023549173A (en) 2020-11-12 2021-10-22 The use of cannabidiol for the treatment of psychological distress
PCT/AU2021/051235 WO2022099347A1 (en) 2020-11-12 2021-10-22 Use of cannabidiol for the treatment of psychological distress
EP21890379.7A EP4243795A1 (en) 2020-11-12 2021-10-22 Use of cannabidiol for the treatment of psychological distress
AU2021378820A AU2021378820A1 (en) 2020-11-12 2021-10-22 Use of cannabidiol for the treatment of psychological distress
KR1020237017129A KR20230107257A (en) 2020-11-12 2021-10-22 Use of cannabidiol for the treatment of psychological distress

Publications (1)

Publication Number Publication Date
AU2020904152A0 true AU2020904152A0 (en) 2020-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP3849549A4 (en) Combination therapy for the treatment of triple-negative breast cancer
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
MX2015014600A (en) 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof.
EP3589287A4 (en) Macrocyclic compounds for treatment of medical disorders
EP3583113A4 (en) Use of tgf alpha for the treatment of diseases and disorders
IL288195A (en) Use of cannabidiol in the treatment of epileptic spasms
EP3883553A4 (en) Aryl-aniline and heteroaryl-aniline compounds for treatment of skin cancers
EP3883554A4 (en) Aryl-aniline and heteroaryl-aniline compounds for treatment of birthmarks
EP3955937A4 (en) Compounds and methods for the treatment of ocular disorders
EP3801340A4 (en) Electro-thermal therapy for the treatment of diseased or unwanted tissue
EP3955926A4 (en) Compounds and methods for the treatment of ocular disorders
EP3937915A4 (en) Novel nano-formulation of cannabidiol (cbd) and other cannabinoids for treatment of skin diseases
EP3877382A4 (en) Novel compounds for the treatment of respiratory diseases
EP3619204A4 (en) Compounds for the treatment of respiratory diseases
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
EP3866673A4 (en) A system for immediate personalized treatment of a patient in a medical emergency
AU2021901086A0 (en) Use of Cannabidiol for the Treatment of Psychological Distress
AU2020904152A0 (en) Use of Cannabidiol for the Treatment of Psychological Distress
AU2022298746A1 (en) Beta-lactam derivatives for the treatment of diseases
EP3744347A4 (en) Composition for skin diseases treatment use
EP4069251A4 (en) Salts and polymorphs of cethromycin for the treatment of disease salts and polymorphs of cethromycin
EP3846803A4 (en) Macrocyclic compounds for the treatment of medical disorders
EP4027984A4 (en) Combination therapy for the treatment of migraines
AU2021901672A0 (en) Use of Cannabidiol for the Treatment of Irritable Bowel Syndrome-Related Psychological Distress
EP3573634A4 (en) Preparation for treatment of wounds